Daily non-political popular news in brief.

Stem cells provide new tool for studying disease and identifying ALS drugs

Results of two studies funded by Project A.L.S. and appearing in today's advance online publication of Nature Neuroscience demonstrate that embryonic stem cells may provide a new tool for studying disease mechanisms and for identifying drugs to slow ALS, also known as Lou Gehrig's disease.

Read more »

Keywords: stem, cells, provide, tool, studying, disease, identifying, als, drugs, cell, drug

« Previous | Next »

Similar news on "Stem cells provide new tool for studying disease and identifying ALS drugs":

1. Immunosuppressive drugs are a double-edged sword to type 1 diabetics
   09-04-2007 · EurekAlert!
   Type 1 diabetes occurs when immune cells destroy pancreatic insulin producing beta-cells. It was hoped that islet transplantation would provide a cure for the disease, however, transplant success is short-lived and accompanied by significant side effects. New data indicate that the immunosuppressive drugs used to prevent islet transplant rejection suppress beta-cell regeneration in diabetic mice, raising the possibility that identifying immunosuppressive drugs that do not inhibit beta-cell regeneration might lead to successful regenerative islet transplantation.
   Similar news · Read more »
   
2. Human stem cells delay start of Lou Gehrig's disease in rats
   10-15-2006 · EurekAlert!
   Researchers at Johns Hopkins have shown that transplanting human stem cells into spinal cords of rats bred to duplicate Lou Gehrig's disease delays the start of nerve cell damage typical of the disease and slightly prolongs life. The grafted stem cells develop into nerve cells that make substantial connections with existing nerves and do not themselves succumb to Lou Gehrig's, also known as amyotrophic lateral sclerosis (ALS). The study is published in this week's issue of Transplantation.
   Similar news · Read more »
   
3. Human Stem Cells Delay Start Of Lou Gehrig's Disease In Rats
   10-15-2006 · ScienceDaily
   Researchers at Johns Hopkins have shown that transplanting human stem cells into spinal cords of rats bred to duplicate Lou Gehrig's disease delays the start of nerve cell damage typical of the disease and slightly prolongs life. The grafted stem cells develop into nerve cells that make substantial connections with existing nerves and do not themselves succumb to Lou Gehrig's, also known as amyotrophic lateral sclerosis (ALS). The study is published in this week's issue of Transplantation.
   Similar news · Read more »
   
4. The power of one: A simpler, cheaper method for cell fusion
   12-04-2006 · EurekAlert!
   It's not easy to make one plus one equal one. But biological engineer Chang Lu has done just that with a new and cheaper method to electrically fuse cells - a vital technology for studying stem cells, creating clones and finding disease antibodies.
   Similar news · Read more »
   
5. Existence of muscle-building stem cells points to regenerative therapies for muscular disease
   05-31-2007 · EurekAlert!
   A new report in the June 1 issue of the journal Cell, a publication of Cell Press, confirms the existence of some apparently uncommitted stem cells amongst cells responsible for generating the bulging biceps of body builders and the rippling abs of fitness buffs. The findings could lead to new muscle-regenerating therapies -- including cell transplantation regimens and stem cell-replenishing drugs -- for people with various muscle-wasting diseases, including muscular dystrophies.
   Similar news · Read more »
   
6. Building stronger bones, 1 stem cell at a time
   01-24-2008 · EurekAlert!
   Mesenchymal stem cells are capable of giving rise to various cell types through a process known as differentiation. A new study has determined that the anti-tumor drug bortezomib targets MSCs and leads to bone cell-specific differentiation. These data led the authors to suggest that Bzb might be a novel therapy for bone loss in individuals with osteoporosis and those with cancers accompanied by severe bone disease, such as myeloma.
   Similar news · Read more »
   
7. Genetic 'Roadmap' Charts Links Between Drugs And Human Disease
   10-02-2006 · ScienceDaily
   A research team led by scientists at the Broad Institute of MIT and Harvard developed a new kind of genetic "roadmap" that can connect human diseases with potential drugs to treat them, as well as predict how new drugs work in human cells. Called the "Connectivity Map," the tool and its uses are described in the September 29 issue of Science and in separate publications in the September 28 immediate early edition of Cancer Cell.
   Similar news · Read more »
   
8. Virginia Tech's System X supercomputer provides super tool for simulation of cell division
   01-30-2007 · EurekAlert!
   Virginia Tech researchers in computer science and biology have used the university's supercomputer, System X, to create models and algorithms that make it possible to simulate the cell cycle -- the processes leading to cell division. They have demonstrated that the new mathematical models and numerical algorithms provide powerful tools for studying the complex processes going on inside living cells.
   Similar news · Read more »
   
9. Modeling lung cancer
   02-12-2007 · EurekAlert!
   In a new report in the February 15 issue of G&D, Dr. Martin McMahon and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.
   Similar news · Read more »
   
10. Stem cells show promise for treating Huntington's disease
    09-25-2007 · EurekAlert!
    Paying close attention to how a canary learns a new song has helped scientists open a new avenue of research against Huntington's disease -- a fatal disorder for which there is currently no cure or even a treatment to slow the disease. Scientists used gene therapy to guide the development of endogenous stem cells in the brains of mice affected by a form of Huntington’s, generating new medium spiny neurons -- the cell lost in Huntington's disease.
    Similar news · Read more »